9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -16.25% | -27.53% | 15.95% | 1.95% | -18.80% |
| Total Depreciation and Amortization | -48.00% | 56.25% | -42.86% | 75.00% | -44.83% |
| Total Amortization of Deferred Charges | -56.52% | 166.05% | -- | -- | -- |
| Total Other Non-Cash Items | 203.98% | -38.04% | -71.28% | 229.57% | 30.43% |
| Change in Net Operating Assets | 409.74% | 125.58% | -265.90% | 17.02% | -13.36% |
| Cash from Operations | -0.11% | 2.32% | -28.05% | 20.13% | -22.30% |
| Capital Expenditure | -- | -- | -- | 100.00% | -7.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -7.69% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -126.27% | -197.96% | 227.68% | 20.15% | -47.40% |
